Clinical Trial Update: a4b7 Integrin in Eosinophilic Esophagitis

View source ↗

Summary

A completed clinical trial evaluating alpha4beta7 integrin in eosinophilic esophagitis sponsored by Massachusetts General Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Eosinophilic Esophagitis | Status: COMPLETED